Trial Comparing Niraparib-bevacizumab-Dostarlimab and Niraparib-bevacizumab to Standard of Care in Recurrent Ovarian Cancer
Clinical trial NCT03806049 · WITHDRAWN
Trial details
- NCT number
- NCT03806049
- Sponsor
- Nordic Society of Gynaecological Oncology - Clinical Trials Unit
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-01
- Primary completion
- 2022-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.